J Biol Chem, Vol. 275, Issue 3, 1773-1780, January 21, 2000
The HPr Kinase from Bacillus subtilis Is a
Homo-oligomeric Enzyme Which Exhibits Strong Positive Cooperativity for
Nucleotide and Fructose 1,6-Bisphosphate Binding*
Jean-Michel
Jault
,
Sonia
Fieulaine§,
Sylvie
Nessler§,
Philippe
Gonzalo
,
Attilio
Di Pietro
,
Josef
Deutscher¶, and
Anne
Galinier
From the
Institut de Biologie et Chimie des
Protéines, UPR 412 CNRS, 69367 Lyon Cedex 07, France, the
§ Laboratoire d'Enzymologie et de Biochimie Structurales,
UPR 9063 CNRS, bât. 34, 91198 Gif-sur-Yvette, France, and the
¶ Laboratoire de Génétique des Microorganismes, INRA
and CNRS ERS-567, 78850 Thiverval-Grignon, France
 |
ABSTRACT |
Carbon catabolite repression allows bacteria to
rapidly alter the expression of catabolic genes in response to the
availability of metabolizable carbon sources. In Bacillus
subtilis, this phenomenon is controlled by the HPr kinase (HprK)
that catalyzes ATP-dependent phosphorylation of either HPr
(histidine containing protein) or Crh (catabolite repression HPr) on
residue Ser-46. We report here that B. subtilis HprK forms
homo-oligomers constituted most likely of eight subunits. Related to
this complex structure, the enzyme displays strong positive
cooperativity for the binding of its allosteric activator, fructose
1,6-bisphosphate, as evidenced by either kinetics of its
phosphorylation activity or the intrinsic fluorescence properties of
its unique tryptophan residue, Trp-235. It is further shown that
activation of HPr phosphorylation by fructose 1,6-bisphosphate
essentially occurs at low ATP and enzyme concentrations. A positive
cooperativity was also detected for the binding of natural nucleotides
or their 2'(3')-N-methylanthraniloyl derivatives, in either
phosphorylation or fluorescence experiments. Most interestingly,
quenching of the HprK tryptophan fluorescence by using either iodide or
acrylamide revealed a heterogeneity of tryptophan residues within the
population of oligomers, suggesting that the enzyme exists in two
different conformations. This result suggests a concerted-symmetry
model for the catalytic mechanism of positive cooperativity displayed
by HprK.
 |
INTRODUCTION |
In bacteria, the histidine-containing protein
(HPr)1 participates in the
phosphotransferase system-catalyzed transport and phosphorylation of
carbohydrates (1). Being part of a protein phosphorylation chain, HPr
is phosphorylated by enzyme I at His-15, in the presence of
phosphoenolpyruvate (2), and transfers the phosphoryl group to a
sugar-specific enzyme IIA. In Gram-positive bacteria, the
phosphoryl-carrier protein HPr is also phosphorylated at a regulatory
serine (Ser-46), by the HPr kinase (HprK) in the presence of ATP
(3-8). This ATP-dependent phosphorylation of HPr mediated
by HprK regulates expression of several catabolic genes and therefore
plays a central role in carbon catabolite repression (9). A recently
discovered HPr-like protein of Bacillus subtilis, catabolite
repression HPr (Crh) (10), is likewise phosphorylated by HprK at Ser-46
and involved too in carbon catabolite repression (11). In B. subtilis, phosphorylation by HprK of either HPr or Crh was shown
to be stimulated by fructose 1,6-bisphosphate (FBP) (5, 6, 10). Signal
transduction in carbon catabolite repression continues with a
phosphorylation-mediated protein-protein interaction between HPr or Crh
and the transcriptional repressor/activator CcpA (catabolite control
protein A) (12, 13). The ATP-dependent phosphorylation at
Ser-46 is a prerequisite for the interaction of either HPr or Crh with
CcpA. The resulting protein complexes, CcpA·Ser(P)-HPr or
CcpA·Ser(P)-Crh, specifically interact with an operator site called
catabolite responsive element (11, 14-16).
Although HPr kinase activity was detected 15 years ago in several
Gram-positive bacteria (3, 4) hprK, the gene encoding HprK,
was only recently identified and cloned during the B. subtilis sequencing program. Preliminary characterization of the
purified recombinant B. subtilis HprK showed that it was
indeed able to specifically phosphorylate HPr or Crh (5, 6). Sequence
comparison revealed that this enzyme is found not only in most
Gram-positive bacteria, but also in some pathogenic Gram-negative
bacteria like Bordetella pertussis, Treponema pallidum, and
Neisseriae. The HprKs constitute a new family of protein
kinases which do not contain the domain structure typical for
eukaryotic serine/threonine/tyrosine kinases (17, 18). Instead, an
ATP-binding motif, called the P-loop (or A-motif) and typically found
in some nucleotide-binding proteins such as F1-ATPase or p21ras
(19, 20), has been detected in the primary structure of this new class
of protein kinases. Since disruption of the hprK gene leads
to severe growth defects of the B. subtilis mutant strain, HprK might constitute a potential target for new antimicrobial agents
in pathogenic bacteria (5).
Recent experiments showed that HprK is a bifunctional enzyme which also
possesses Ser(P)-HPr phosphatase activity (8). The molecular switch
between the phosphatase and the kinase activities appears to be
controlled by the presence of low molecular weight effectors. In the
presence of FBP and ATP, the kinase activity of HprK is predominant,
whereas the phosphatase activity becomes prevalent when the
concentration of inorganic phosphate rises (8).
Tryptophan fluorescence provides a very sensitive and widely used tool
to monitor the binding of effectors, especially nucleotides and their
derivatives, to numerous nucleotide-binding proteins (21-25). Since
the molecular mechanism underlying HPr phosphorylation by the recently
discovered HprK was poorly understood, the binding properties of HprK
were first investigated by following the variation of its intrinsic
tryptophan fluorescence in the presence of different effectors. Our
preliminary results suggested that HprK can bind nucleotides or FBP in
a cooperative manner and a thorough characterization of its kinetic
properties was therefore carried out. This report describes the results
obtained from both biochemical and biophysical experiments, and it
unambiguously shows that HprK is a homo-oligomeric enzyme which exists
in two different conformations. This latter property leads most likely
to the positive cooperativity mechanism reported here for the binding
of either nucleotides or FBP. Furthermore, it is shown that the
enhancement of HPr phosphorylation by FBP essentially occurs at low
concentrations of both ATP and HprK.
 |
EXPERIMENTAL PROCEDURES |
Reagents--
N-Methylanthraniloyl (Mant) derivatives
of nucleotides were prepared by reaction of nucleotides with
N-methylisatoic anhydride as described by Hiratsuka (26)
except that the obtained derivatives were purified on DEAE-cellulose
column (27) by elution with a linear gradient of 10 to 800 mM triethylammonium bicarbonate. The fluorescent
nucleotides eluted far after the unreacted nucleotides and the excess
of N-methylisatoic acid. The pooled fractions were dried
under vacuum and remaining triethylamine was removed by three
successive additions and evaporations of methanol. Purity and
homogeneity of the products were tested by both thin-layer chromatography according to Ref. 26 and reverse-phase high performance liquid chromatography using a C-18 column and elution with a 0 to 60%
gradient of acetonitrile in 50 mM potassium phosphate, pH
6.0. The concentration of fluorescent nucleotide was determined by UV
absorbance at 255 nm for MantADP (
= 23,300 M
1 cm
1) and MantGDP (
= 22,600 M
1 cm
1).
Protein Purification--
HPr(His)6 and
HprK(His)6 were purified on Ni-NTA-agarose columns as
described previously (5, 10). Proteins were stored at
80 °C in 20 mM ammonium bicarbonate.
Gel Filtration--
Size exclusion chromatography experiments
were performed on a Superdex 200 HR 10/30 FPLC column (Amersham
Pharmacia Biotech). In all experiments, the equilibration buffer
contained 20 mM Bis-Tris propane, pH 7.0, and 200 mM NaCl. The samples were centrifuged for 10 min at 15,000 rpm at 4 °C prior to loading 500-µl aliquots onto the column at a
protein concentration of 170 µM. The system was
calibrated under the same conditions using the Bio-Rad gel filtration
standard kit. Proteins present in the eluted fractions were analyzed by
SDS-polyacrylamide gel electrophoresis.
Ultracentrifugation--
Analytical ultracentrifugation was
carried out on a Beckman Optima XL-A equipped with an An60Ti four-hole
rotor and a cell with two-channel 12-mm path length centerpieces.
Radial scans of absorbance at 280 nm were performed with the sample
buffer used as blank. Sedimentation-velocity experiments were performed at 30,000 rpm and 4 °C. Apparent sedimentation coefficients of the
species present in the cell were obtained by the time derivative method
of W. Stafford (28) and the SVEDBERG program of Philo (29).
Equilibrium-sedimentation centrifugations were carried out at 5,600, 8,000, and 12,000 rpm at 4 °C. The high molecular weight aggregates
that accumulated at the bottom of the cells were not taken into
account. Determination of the molecular mass was performed with the
software package provided by Beckman. Data were analyzed for average
molecular mass in terms of a single homogeneous species according to
the equation: Ar = A0 exp
[H M (x2
x02)] + E with
H = (1
vbar
)
2/2 RT, where Ar is
the absorbance at radius x, A0 the
absorbance at a reference radius x0,
vbar the partial specific volume of HprK
estimated from its sequence (0.735 ml g
1 at 4 °C),
the solvent density (1.009 g ml
1),
the angular
velocity, R the gas constant, T the absolute temperature, M the molecular mass, and E the
baseline offset.
Protein Phosphorylation--
Phosphorylation of
HPr(His)6 by the HprK(His)6 was carried out as
described previously (5). A typical 20-µl phosphorylation mixture
contained 30 µM purified HPr(His)6, 350 nM purified HprK(His)6, 50 mM
Tris/HCl, pH 8.0, 10 mM MgCl2, and 50 µM ATP, unless otherwise stated in the figure legend. The
reaction mixture was incubated for the time specified in the figure
legends. In all cases, a kinetic experiment was performed under the
same conditions to ensure that an initial rate of phosphorylation was
maintained during the time interval chosen. The phosphorylation
reaction was stopped by adding 100 mM EDTA to the assay
mixtures before loading the samples onto a nondenaturing 12.5%
polyacrylamide gel. On this type of gels, phosphorylated HPr is well
separated from the unphosphorylated protein (30). After
electrophoresis, the gel was stained with Coomassie Blue and scanned in
a Densitometer SI (Molecular Dynamics); results were analyzed with the
ImagQuant V1.2 software (Molecular Dynamics). For each sample, the
percent of Ser(P)-HPr was automatically calculated by integrating the area of the lower band relatively to that of the upper band,
corresponding to phosphorylated and unphosphorylated HPr, respectively.
Fluorescence Measurements--
All experiments were performed at
25 ± 0.1 °C using a Photon Technology International Quanta
Master I spectrofluorometer. The measurements were automatically
corrected for intensity fluctuation in lamp emission. All spectra were
corrected for buffer fluorescence. Fluorescence measurements were
routinely carried out after dilution of HprK (1 µM final
concentration) and equilibration for 10 min in 2 ml of buffer
containing 25 mM Hepes/KOH, pH 8.2, and 0.1 mM
EDTA (except where stated otherwise). Increasing concentrations of
nucleotides, Mant-derivatives, or FBP were then added and the emission
fluorescence was scanned in the range of either 310-380 nm for
nucleotides or FBP or 310-530 nm for Mant-derivatives, upon excitation
at 295 nm. Binding of ligands was monitored by the variation of
tryptophan-intrinsic fluorescence of HprK (between 310 and 380 nm)
produced after addition of increasing concentrations of effectors, and
corrections for both the variation of volume and the inner-filter
effect of the ligands were performed under the same conditions by using
N-acetyltryptophanamide. Fluorescence resonance-energy
transfer between tryptophan residues of HprK and bound Mant-nucleotide
derivatives was monitored by the appearance of a fluorescence emission
peak between 400 and 530 nm, characteristic of bound nucleotide
analogues. Peak integration was carried out at each ligand
concentration with the Felix 1.21 software (Photon Technology
International) and the observed changes in fluorescence intensity or
fluorescence resonance-energy transfer were used for the calculation of
ligand affinity. Curve fitting of the data was performed using either
the Graphit 2.11 software (Erithacus Software) for the monophasic
binding of effectors as described in Ref. 31, or the MacCurvefit 1.0.8 software for the cooperative binding of effectors.
Quenching experiments in the presence of either potassium iodide or
acrylamide were performed by successive additions of aliquots from
concentrated stock solutions. The potassium iodide stock solution also
contained 0.1 mM potassium thiosulfate in order to prevent
I3
formation, which would quench
tryptophan fluorescence emission (32). A control experiment conducted
with similar concentrations of KCl indicated that ionic strength did
not significantly modify the fluorescence emission of HprK. In the case
of acrylamide, the inner-filter effect at the emission wavelength was
corrected according to Calhoun et al. (33). The fluorescence
quenching data in the presence of either acrylamide or iodide were
analyzed according to the Stern-Volmer equation (34, 35) which, when all quenching is collisional (no static quenching), is:
Fo/F = 1 + Ksv[Q], where Fo
and F are the fluorescence intensities in the absence or
presence of quenchers, respectively, Ksv the collisional Stern-Volmer constant, and [Q] the quencher
concentration. The plot of Fo/F
versus [Q] is linear if the population of
emitting fluorophores is homogenous. In contrast, a downward curvature
is observed for a heterogenous population of fluorophores, and a linear
plot can then be obtained by using the modified Stern-Volmer relationship introduced by Lehrer (36):
Fo/(Fo
F) = 1/([Q]faKQ) + 1/fa where fa is the fractional
number of accessible fluorophores and KQ their
collisional constant. The plot of
Fo/(Fo
F)
versus 1/[Q] allows a graphical determination
of fa.
 |
RESULTS |
HprK from B. subtilis Is a Homo-oligomeric Enzyme--
Analysis of
the HprK oligomerization state was first undertaken by size exclusion
chromatography. At the elution volume expected for the monomer (36 kDa), a very small peak was observed the composition of which has not
been determined. The major peak containing HprK eluted at a volume
corresponding to about 260 kDa, indicating that this enzyme is highly
oligomeric (data not shown). Analysis of the chromatograms revealed a
small shoulder at the leading edge of the peak, suggesting that some
aggregation occurred during the experiments. No noticeable change in
the protein elution volume was observed when HprK was incubated with
ATP-Mg or FBP prior loading onto the column. In order to obtain
additional information on the size of HprK, an analytical
ultracentrifugation was conducted on the protein. First, homogeneity
was tested by a sedimentation-velocity experiment. A major population
(about 85%) was observed with an apparent sedimentation coefficient of
s20 °C = 9.2. Minor populations of higher
molecular weight were also observed. The quaternary structure of HprK
was studied by sedimentation-equilibrium analytical
ultracentrifugation. The experiment was performed at three different
ultracentrifugation speeds and repeated three times. Each of the 9 data
sets analyzed separately gave a single homogeneous species of average
molecular mass 240-320 kDa. A simultaneous fit was then performed
yielding an average mass of 274,200 Da, corresponding to 7.6 times the
calculated molecular mass of the monomer, i.e. 36,068 (Fig.
1). This result suggests that the native form of B. subtilis HprK is an octamer, although the
possibility of a more rarely observed heptamer cannot be ruled out.

View larger version (22K):
[in this window]
[in a new window]
|
Fig. 1.
Equilibrium sedimentation of HprK. The
absorbance at 280 nm is plotted against the radial position expressed
in centimeters. The upper part of the figure shows the
residual difference between experimental and fitted values by its
standard deviation. This experiment was carried out at three different
centrifugation speeds, and repeated three times for each centrifugation
speed. An identical fit was performed for all nine experiments, but
only the result obtained with HprK at 5,600 rpm is shown here for more
clarity. The other eight fits were of the same quality.
|
|
FBP Stimulates the Phosphorylation of HPr and Its Binding to HprK
Follows a Positive Cooperativity Mechanism--
In order to
investigate the effect of FBP on HprK, the initial rate of HPr
phosphorylation was analyzed at low concentrations of both HprK and ATP
and increasing concentrations of FBP (Fig. 2). The results show that no stimulation
of HPr phosphorylation was observed at FBP concentrations below 1 mM. However, when the FBP concentration was raised above 1 mM, HPr phosphorylation by HprK was strongly stimulated,
and after a sharp increase, the activity reached a plateau at about 5 mM FBP. The sigmoidal curve in Fig. 2 suggests that binding
of FBP to HprK, HPr, or to both proteins follows a positive
cooperativity mechanism.

View larger version (49K):
[in this window]
[in a new window]
|
Fig. 2.
Effect of increasing FBP concentrations on
HPr phosphorylation by HprK. A, 20 µl of a
phosphorylation mixture contained 30 µM HPr, 350 nM purified HprK, 50 mM Tris/HCl, pH 8, 10 mM MgCl2, 25 µM ATP and the
following concentrations of FBP: 0 mM (lane 1),
0.5 mM (lane 2), 1 mM (lane
3), 2.5 mM (lane 4), 7.5 mM
(lane 5), 10 mM (lane 6), 15 mM (lane 7), 20 mM (lane
8). The phosphorylation mixture was incubated for 10 min at
37 °C and the reaction was stopped by adding 100 mM EDTA
before loading samples onto nondenaturing 12.5% polyacrylamide gel
(30). After electrophoresis, the gel was stained with Coomassie Blue.
The upper band represents HPr, the lower band
Ser(P)-HPr. B, the gel was scanned in a personal
Densitometer SI and the data were analyzed with the software ImagQuant
V1.2 (Molecular Dynamics). The figure represents the percent of HPr
which is phosphorylated in response to increasing concentrations of
FBP.
|
|
Evidence for direct binding of FBP to HprK was provided by the results
presented in Fig. 3. We took advantage
that HprK contains a single tryptophan (Trp-235) in its sequence
(SWISS-PROT accession number 034483) to study FBP binding by intrinsic
fluorescence measurements. In the absence of FBP and with the
excitation wavelength set at 295 nm, HprK exhibited a fluorescence
emission spectrum characteristic of a rather accessible tryptophan
residue (
max around 340 nm) (Fig. 3A, lower
curve). A progressive increase of the FBP concentration from 0.5 to 12 mM enhanced the fluorescence intensity of HprK (Fig.
3A, upper curves). When the ratio of the HprK
fluorescence intensity measured in the presence and absence of FBP
(F/Fo) was plotted as a function of the
FBP concentration, a sigmoidal curve was obtained confirming that FBP
binding to HprK follows a positive cooperativity mechanism (Fig.
3B). Curve fitting of the data allowed estimation of the
parameters for binding of FBP to HprK
(Fmax/Fo = 1.46 ± 0.0062; nH = 2.19 ± 0.067 and apparent
KD = 6.03 mM). The apparent discrepancy
between the maximal concentrations of FBP required to stimulate the
kinase activity in phosphorylation tests (Fig. 2) and to saturate the
FBP-binding site of HprK in fluorescence experiments (Fig.
3B) might be due to different temperatures used (25 and
37 °C for fluorescence and kinetic experiments, respectively) but
also to differences in buffer composition, for instance, the lack of
magnesium in the fluorescence experiments. Magnesium was omitted from
the fluorescence buffer since it produced a slow precipitation of the
protein during the experiment. Addition of agents known to stabilize
proteins, such as 20% glycerol or use of different buffers, did not
solve this problem. As a consequence, the fluorescence experiments were
carried out in the absence of magnesium. The effect of FBP on HprK
fluorescence seems to be very specific, as neither fructose 1-phosphate
nor fructose 6-phosphate had any significant effect on the fluorescence
emission spectrum of the kinase (Fig. 3B). This indicates
that either these two compounds do not bind to HprK or that they do
bind to the enzyme but without inducing any conformational change.
Accordingly, fructose 1-phosphate and fructose 6-phosphate were without
effect on the phosphorylation activity of HprK (data not shown
(6)).

View larger version (18K):
[in this window]
[in a new window]
|
Fig. 3.
Effect of FBP on the HprK tryptophan
fluorescence. A, increasing concentrations of FBP were
added to a 2-ml mixture containing 1 µM HprK, and the
fluorescence intensity was recorded after each addition as described
under "Experimental Procedures." From the lower to the upper
curves, the concentration of FBP was 0, 2, 4, 5.9, 7.8, 9.8, and 11.7 mM, respectively. Each curve was corrected for the
fluorescence of the buffer alone containing the same concentration of
FBP. B, the increase in HprK fluorescence produced by FBP
binding was plotted versus the concentration of FBP ( ),
after correction for the inner-filter effect of FBP on
N-acetyltryptophanamide. Identical experiments were carried
out using fructose 1-phosphate ( ) or fructose 6-phosphate ( )
instead of FBP.
|
|
Tryptophan Heterogeneity Reveals a Heterogenous Population of HprK
Oligomers--
The positive cooperativity displayed by HprK for
binding of FBP implies that this enzyme contains at least two classes
of FBP-binding sites. Whether the binding of FBP to (a) high
affinity site(s) induced a change in the affinity of a second class of FBP-binding sites within the same HprK oligomer (by sequential interaction (37)) or whether this reflected an equilibrium between two
oligomer conformations of the enzyme (by concerted symmetry (38)) was
not known. To decide between the two alternatives, the accessibility of
tryptophan residues was assessed by using either acrylamide or iodide.
As shown in Fig. 4A, addition
of increasing amounts of iodide, a compound known to quench only surface accessible tryptophan residues (39), to native HprK caused a
progressive quenching of intrinsic fluorescence. However, a downward
curvature was observed in the Stern-Volmer plot for iodide
concentrations above 80 mM. This curvature indicates that the population of tryptophan residues is heterogenous. This was confirmed by the modified Stern-Volmer plot (Fig. 4B), which
allowed estimation of the fraction of tryptophan residues accessible to iodide, fa, found to be about 0.5. The iodide effect was not caused by any denaturation of HprK, since the enzyme
preincubation with 0.2 M potassium iodide for 1 h
prior to measuring its activity by diluting it 1000-fold in an HPr
kinase assay mixture did not alter HprK activity (data not shown here).
Preincubation of HprK with 20 mM FBP tended to flatten the
curve of the Stern-Volmer plot which was reflected by an increase in
the fraction of tryptophan residues accessible to iodide
(fa = 0.61). In a control experiment, denatured
HprK, obtained by incubation with 6 M guanidine hydrochloride for 16 h, was also found to give a linear
Stern-Volmer plot, but under these conditions all the tryptophan
residues became accessible to iodide (fa of about
1). The same experiment was conducted by using acrylamide, a nonpolar
quencher which have facilitated access to some of the buried
tryptophans (39). In this case, however, the presence of FBP did not
significantly change the fraction of tryptophan residues accessible to
acrylamide (fa of about 0.7), although it slightly
increased the collisional quenching constant (KQ = 6.63 M
1 as compared with 4.99 M
1, data not shown). The
fa values, significantly lower than 1, indicate an
inherent heterogeneity within the population of HprK oligomers. A
fa value of 1 would be expected if HprK followed a
sequential model of cooperativity, since, in that case, all the
monomers should be equivalent (40). Conversely, these results are
consistent with a concerted-symmetry model for the HprK allosteric
transition, where the population of oligomers pre-exists in two
different conformations (38).

View larger version (16K):
[in this window]
[in a new window]
|
Fig. 4.
Quenching of HprK fluorescence by
iodide. Increasing concentrations of potassium iodide were added
to a 2-ml mixture containing either 1 µM HprK ( ), 1 µM HprK preincubated for 10 min with 20 mM
FBP ( ), or 1 µM HprK preincubated overnight with 6 M guanidine hydrochloride ( ), and the fluorescence
intensity was recorded after each addition. Fo and
F are integrated values of fluorescence intensities
determined from the emission spectrum (between 310 and 380 nm) recorded
in the absence and presence of iodide, respectively, and corrected for
the fluorescence of the buffer alone containing the same concentration
of iodide. The data are plotted using a Stern-Volmer representation
(A) or a modified Stern-Volmer representation according to
Lehrer (36) (B).
|
|
FBP Binding Efficiently Stimulates Phosphorylation of HPr at Low
ATP Concentrations without Apparently Changing the Affinity of HprK for
ATP--
In order to study in more detail the role of FBP in HPr
phosphorylation by HprK, increasing concentrations of ATP were used in
the presence or absence of 5 mM FBP. The kinase activity
was determined by loading the assay mixtures onto nondenaturing
polyacrylamide gels which permit separation of phosphorylated from
nonphosphorylated HPr (30). The results clearly indicated that HPr
phosphorylation was stimulated by FBP (Fig.
5, A and B).
Nevertheless, the effect of FBP was more obvious at ATP concentrations
lower than 0.4 mM (Fig. 5C). For ATP
concentrations between 0.075 and 0.2 mM, HPr phosphorylation was barely detectable in the absence of FBP whereas a
strong proportion of HPr, around 60%, was phosphorylated in the
presence of FBP (Fig. 5, A and B, lanes
4-6).

View larger version (37K):
[in this window]
[in a new window]
|
Fig. 5.
Effect of FBP on HPr phosphorylation by
HprK. 20 µl of a phosphorylation mixture contained 30 µM HPr, 350 nM HprK, 50 mM
Tris/HCl, pH 8, 10 mM MgCl2, and the following
concentrations of ATP: 0 mM (lane 1), 0.025 mM (lane 2), 0.05 mM (lane
3), 0.075 mM (lane 4), 0.1 mM
(lane 5), 0.2 mM (lane 6), 0.4 mM (lane 7), 0.6 mM (lane
8), 0.8 mM (lane 9), and 1 mM
(lane 10). Phosphorylation activity was determined by
electrophoresis on nondenaturing gels. A, incubation was
carried out at 37 °C for 10 min in the absence of FBP. B,
incubation was carried out at 37 °C for 5 min in the presence of 5 mM FBP. C, the gel was scanned as described in
Fig. 2 and the percentage of phosphorylation is reported for each ATP
concentration: in the absence of FBP ( ) or in the presence of 5 mM FBP ( ).
|
|
To further assess the role of FBP in the HprK phosphorylation activity,
it was tested whether FBP was able to alter the affinity of nucleotide
binding to HprK. In the absence of FBP, ATP binding to HprK produced an
increase in HprK fluorescence intensity (Fig. 6A). Curve fitting of the
results allowed estimation of the binding parameters for ATP binding,
KD = 270 ± 21 µM and
Fmax = 1.28 ± 0.008. Likewise, binding of
GTP, which was previously shown to be an alternative phosphate donor
for HPr phosphorylation by HprK (6), produced a similar increase in the
kinase fluorescence intensity (Fmax = 1.25 ± 0.008), with a somewhat higher affinity (KD = 116 ± 11 µM). Conversely, when FBP was bound to the
HprK, which already led to an increase of the fluorescence intensity by
about 40% (cf. Fig. 3), the addition of either ATP or GTP
produced a significant quenching of the fluorescence intensity (21 ± 0.5 and 8 ± 0.9%, respectively). Nevertheless, the binding affinity for both nucleotides was only slightly affected by the presence of FBP with a KD of 363 ± 21 µM for ATP or 88 ± 29 µM for GTP.
Therefore, the FBP enhancement of HPr phosphorylation at low ATP
concentrations did not appear to be related to any increase in
nucleotide affinity. However, as the fluorescence experiments had to be
conducted in the absence of magnesium (see above), a pronounced effect
of FBP on nucleotide binding in the presence of magnesium might have
been overlooked.

View larger version (17K):
[in this window]
[in a new window]
|
Fig. 6.
Effect of nucleotides on the HprK
fluorescence. Increasing concentrations of either ATP ( ) or GTP
( ) were added to a 2-ml mixture containing either 1 µM
HprK (A) or 1 µM HprK preincubated for 10 min
with 20 mM FBP (B), and the fluorescence
intensity was recorded after each addition, as described under
"Experimental Procedures." The ratio of the fluorescence intensity
measured in the absence and presence of nucleotides was plotted against
the nucleotide concentration.
|
|
HprK Exhibits a Positive Cooperativity for Nucleotide
Binding--
The results presented in Fig. 5C, obtained in
the absence of FBP, suggested that ATP binding to HprK followed a
positive cooperativity mechanism and this was further investigated.
Fig. 7 shows no HprK-mediated HPr
phosphorylation at low ATP concentrations. However, when the ATP
concentration was raised above 0.1 mM, a progressive
increase in activity was observed until a maximal level of
phosphorylation was attained at about 5 mM ATP. A sigmoidal
curve was readily seen when only low ATP concentrations were analyzed
(cf. inset, Fig. 7B)

View larger version (45K):
[in this window]
[in a new window]
|
Fig. 7.
Phosphorylation of HPr in the presence of
different amounts of ATP. A, 20 µl of a
phosphorylation mixture, which was incubated for 10 min at 37 °C,
contained 30 µM HPr, 2.8 µM purified HprK,
50 mM Tris/HCl, pH 8, 10 mM MgCl2
and the following concentrations of ATP, 0 mM (lane
1), 0.025 mM (lane 2), 0.05 mM
(lane 3), 0.1 mM (lane 4), 0.5 mM (lane 5), 1 mM (lane
6), 5 mM (lane 7), 10 mM
(lane 8). The phosphorylation reaction was stopped by adding
100 mM EDTA to the assay mixtures before loading them onto
a nondenaturing 12.5% polyacrylamide gel gel. B, the gel
was scanned as described in the legend of Fig. 2 and the percentage of
phosphorylation is reported for each ATP concentration.
Inset is a blow-up of the plot obtained at low ATP
concentrations.
|
|
Positive cooperativity for nucleotide binding was further detected when
carrying out fluorescence studies in the presence of magnesium. To
avoid the precipitation of HprK induced by the presence of magnesium
alone, equimolar amounts of magnesium and ADP were used. Under these
conditions no precipitation of HprK occurred. The results of such an
experiment are reported in Fig. 8. No
effect on the fluorescence emission spectrum was seen until the
concentration of both magnesium and ADP reached about 50 µM. At higher concentrations, a quenching of tryptophan
fluorescence was observed. Binding of fluorescent nucleotide analogues,
i.e. Mant derivatives, was also found to follow a positive
cooperativity mechanism, as can be seen from the experiment with
MantADP shown in Fig. 9. Addition of
increasing amounts of MantADP together with equimolar amounts of
magnesium produced a drastic quenching of the fluorescence emission
spectrum of HprK tryptophan residues (Fig. 9A, left
side). Simultaneously, a new peak of fluorescence progressively
developed, centered at approximately 430 nm, which is related to
fluorescence resonance energy transfer between the tryptophan residues
and the Mant group. The plot of fluorescence quenching as a function of
MantADP-Mg concentration clearly shows that the nucleotide analogue
binding followed a biphasic process, reflecting a positive
cooperativity mechanism (Fig. 9B). Accordingly, the
fluorescence resonance energy transfer plotted versus the concentration of MantADP-Mg also exhibited a biphasic dependence confirming a mechanism of positive cooperativity for MantADP binding. Curve fitting of the results obtained from either the quenching (Fig.
9A) or the energy transfer (Fig. 9B) experiments
allowed estimation of the following binding parameters for the
MantADP-Mg: nH = 2.06 ± 0.17 and apparent
KD = 21.87 µM, or nH = 2.26 ± 0.13 and apparent KD = 16.55 µM, respectively. That the Mant analogue was actually
able to bind to the nucleotide-binding site of HPrK was demonstrated by the ability of MantATP to efficiently replace ATP, although to a lower
extent, during a HPr phosphorylation assay (not shown). When the
MantGDP replaced MantADP, a similar positive cooperativity of binding
was also obtained. Likewise, MantGTP proved to be an efficient
phosphate donor for HPr phosphorylation by HprK confirming that MantGTP
and -GDP do bind to the nucleotide-binding site of HprK (data not
shown).

View larger version (17K):
[in this window]
[in a new window]
|
Fig. 8.
Effect of ADP-Mg on the HprK
fluorescence. Increasing concentrations of ADP-Mg ( ) were added
to a 2-ml mixture containing 1 µM HprK in 25 mM Hepes/KOH, pH 8.2, and the fluorescence intensity was
recorded after each addition as described under "Experimental
Procedures." The ratio of the fluorescence intensity measured in the
absence and presence of nucleotides was plotted against the ADP-Mg
concentration.
|
|

View larger version (16K):
[in this window]
[in a new window]
|
Fig. 9.
Effect of MantADP-Mg on HprK
fluorescence. Increasing concentrations of MantADP-Mg were added
to a 2-ml mixture containing 1 µM HprK in 25 mM Hepes/KOH, pH 8.2, and the fluorescence intensity was
recorded after each addition as described under "Experimental
Procedures." A, the emission spectrum of HprK fluorescence
was recorded at different micromolar concentrations of MantADP-Mg as
indicated in the figure. B, the fluorescence quenching
obtained from the integrated peak of fluorescence (between 310 and 380 nm), in the presence as compared with the absence of MantADP-Mg, was plotted
against the concentration of MantADP-Mg, after correction for the inner
filter effect of MantADP-Mg measured on
N-acetyltryptophanamide. C, the fluorescence
resonance energy transfer, taken as the increase in fluorescence
between 400 and 530 nm, was plotted against the concentration of
MantADP-Mg.
|
|
 |
DISCUSSION |
This paper describes the first thorough characterization of the
enzymatic properties of the HprK from B. subtilis, a member of a recently identified new class of bacterial protein kinases unrelated to the eukaryotic protein kinase family (5, 6). The
combination of biochemical and biophysical approaches used in this
study allowed us to shed some light on the mechanistic properties of
this enzyme. The new information reported in this paper includes (i)
the oligomeric nature of B. subtilis HprK, which probably
forms an octamer; (ii) the permanent asymmetry among the population of
HprK oligomers; (iii) the pronounced positive cooperativity exhibited
by HprK for the binding of either nucleotides or its allosteric
activator, FBP, conceivably a consequence of the heterogeneity of HprK
oligomers; (iv) the role of FBP at low ATP concentrations; (v) the
properties of the unique tryptophan, Trp-235, present in the B. subtilis enzyme sequence and ideally located to sense the
conformational changes induced by the binding of different effectors.
Homo-oligomeric Structure of HprK--
The high oligomerization
state (with an average molecular mass of 274 kDa) suggests that the
native form of B. subtilis HprK is an octamer. An even
higher oligomerization state has previously been reported for HprK from
Streptococcus salivarius, compatible with a decamer
structure (7). In that study, however, the molecular weight was only
estimated from size exclusion chromatography and this result needs to
be confirmed using a method independent of the shape of the molecule,
such as equilibrium-sedimentation centrifugation. More surprising is
the case of HprK isolated from Enterococcus faecalis, for
which a dimeric structure has been determined by using gel filtration
chromatography (8). Whether this apparent lower supramolecular
structure may be related to an altered binding behavior toward
effectors such as FBP (see here after) awaits to be tested.
Heterogeneity of the Enzyme Oligomers and Positive
Cooperativity--
The presence of a single tryptophan residue in the
enzyme monomer allowed detection that the HprK oligomers exist in two
different conformations. Addition of quenching agents such as iodide or acrylamide revealed a heterogeneity among the tryptophan residues. This
heterogeneity could well explain the properties of positive cooperativity exhibited by the enzyme for the binding of either nucleotides (or analogues) or FBP. Additionally, this suggests that the
mechanism of positive cooperativity exhibited by HprK falls into the
category of concerted allosteric transition as first proposed by Monod
et al. (38) and later demonstrated for aspartate
transcarbamoylase (41). Two previous reports have dealt with the
kinetic properties of HprK isolated from either Streptococcus
pyogenes or S. salivarius, but in both studies it was
concluded that the enzyme binds ATP following Michaelis-Menten (hyperbolic) kinetics (4, 7). This apparent discrepancy might, however,
be explained by the different experimental conditions used in each
report. In the first study, 4 mM FBP was added to the assay
mixture used for HPr phosphorylation (4) which very likely precluded
the detection of any positive cooperativity (see Fig. 5, in the
presence of 5 mM FBP). Although FBP was omitted from the
assay medium, in the second study, the concentration of ATP varied
between approximately 0.6 and 5 mM (7) which might have
hampered the finding of a lag at lower ATP concentrations. Accordingly,
the Km values reported for ATP were quite different
for the two enzymes: 66 µM for S. pyogenes and
1 mM for S. salivarius.
FBP Is an Allosteric Activator of B. subtilis HprK at Low ATP
Concentrations--
The role of FBP as an activator of HPr
phosphorylation has been previously determined by using either crude
extracts or partially purified HprKs from many species including
B. subtilis (10), S. pyogenes (42),
Streptococcus mutans (43), S. salivarius (44),
E. faecalis (3), and Listeria monocytogenes (45, 46). However, contradictory results have been reported with purified
HprK. For instance, the phosphorylation activity of the B. subtilis recombinant enzyme has been shown to be strongly
stimulated by FBP (5, 6), whereas that obtained from either E. faecalis (8) or S. salivarius (7) was not. A tentative
explanation for the lack of FBP activation observed in the two latter
studies is that the concentration of HprK, ATP, or both was too high
thus preventing the detection of FBP stimulation. Indeed, the results of Fig. 5 show that the FBP effect is mostly observed at low ATP concentrations but also when a low concentration of HprK is used. It is
also possible that the allosteric activation caused by FBP occurs only
with certain members of the HprK family. It will be interesting to
investigate whether the difference in the quaternary structure of some
HprKs, a dimer in E. faecalis as opposed to an octamer in
B. subtilis, might be related to different regulation mechanisms, i.e. activation of HprK by FBP for the B. subtilis but not for the E. faecalis enzyme.
The results reported here indicate that FBP is an allosteric activator
and that its binding to B. subtilis HprK obeys a positive cooperative mechanism. This mechanism allows a rapid adaptation of
metabolic enzymes to subtle variations of their intracellular effector
concentrations. FBP is one of the first glycolytic intermediates and
its concentration is 14-fold higher when B. subtilis is
grown in the presence of glucose as compared with cells grown in the presence of malate (47). Consequently, this is a well suited activator
to switch on the activity of the HprK, which then triggers the whole
mechanism of carbon catabolite repression. It is noteworthy that in the
microbiological world, FBP is often used as an allosteric effector of
metabolic enzymes involved in sugar utilization (48), such as pyruvate
kinase from yeast (49) or Lactococcus lactis (3, 50),
B. stearothermophilus lactate dehydrogenase (51), or
Escherichia coli glycerol kinase (52). FBP acts as an
allosteric activator for pyruvate kinase and lactate dehydrogenase,
which are both involved in glucose utilization. By contrast, the
activity of glycerol kinase, which is repressed by the presence of
glucose, is allosterically inhibited by high concentrations of FBP.
The molecular mechanism allowing the stimulation by FBP of B. subtilis HprK activity is presently unknown. In the absence of
magnesium, FBP does not significantly alter the affinity for nucleotide
binding, but we cannot rule out an effect on nucleotide affinity in the
presence of magnesium. Alternatively, FBP can increase either the
binding of the substrate, HPr, or the velocity of the
phosphoryl-transfer step.
Strategic Location of Trp-235 in the HprK Structure--
The
single tryptophan residue present in the sequence of B. subtilis HprK appears to be ideally located in the enzyme to allow monitoring of the conformational changes associated with the binding of
FBP, nucleotides, or nucleotide analogues. Comparison with other
members of the HprK family revealed that a tryptophan residue is
sometimes found at the same position such as in T. pallidum or E. faecalis, but it can be replaced by a phenylalanine, a
leucine, or even an alanine residue in other species (5, 6).
Nevertheless, the tryptophan residue in B. subtilis HprK
must be located in close proximity to the nucleotide-binding site due
to the quenching of fluorescence observed when either ATP or GTP were
added to HprK in the presence of FBP, or when ADP-Mg was added to HprK in the absence of FBP. A drastic quenching effect was observed with
MantADP-Mg (up to about 87%) accompanied by a high fluorescence resonance energy transfer leading to the appearance of a new emission peak and suggesting that the Mant moiety is also rather close to
Trp-235.
 |
ACKNOWLEDGEMENTS |
We are grateful to J. Janin, in whose
laboratory part of this work was carried out, for continuous
encouragement and critical reading of the manuscript. We thank G. Batelier for the ultracentrifugation experiments as well as J. Philo
and W. Stafford for making the computer programs available on the RASMB
server. We are thankful to A. Bosch for help with iconography and S. Grael for excellent technical assistance.
 |
FOOTNOTES |
*
This work was supported by the CNRS, the Université de
Lyon, and the Université d'Orsay.The costs of publication of this article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
To whom correspondence should be addressed: Institut de
Biologie et Chimie des Protéines, UPR 412 CNRS, 7 Passage du
Vercors, F-69367 Lyon Cedex 07, France. E-mail: a.galinier@ibcp.fr;
Tel.: 33-472722679; Fax: 33-472722601.
 |
ABBREVIATIONS |
The abbreviations used are:
HPr, histidine
containing protein;
FBP, fructose 1,6-bisphosphate;
CcpA, catabolite
control protein A;
Crh, catabolite repression HPr;
HprK, HPr kinase;
PAGE, polyacrylamide gel electrophoresis;
Mant, 2'(3')-N-methylanthraniloyl;
Bis-Tris, 2-[bis(2-hydroxyethyl)amino]-2-(hydroxymethyl)-propane-1,3-diol.
 |
REFERENCES |
| 1.
|
Kundig, W.,
Ghosh, S.,
and Roseman, S.
(1964)
Proc. Natl. Acad. Sci. U. S. A.
52,
1067-1074[Free Full Text]
|
| 2.
|
Gassner, M.,
Stehlik, D.,
Schrecker, O.,
Hengstenberg, W.,
Maurer, W.,
and Rüterjans, H.
(1977)
Eur. J. Biochem.
75,
287-296[Medline]
[Order article via Infotrieve]
|
| 3.
|
Deutscher, J.,
and Engelmann, R.
(1984)
FEMS Microbiol. Lett.
23,
157-162[CrossRef]
|
| 4.
|
Reizer, J.,
Novotny, M. J.,
Hengstenberg, W.,
and Saier, M. H., Jr.
(1984)
J. Bacteriol.
160,
333-340[Abstract/Free Full Text]
|
| 5.
|
Galinier, A.,
Kravanja, M.,
Engelmann, R.,
Hengstenberg, W.,
Kilhoffer, M. C.,
Deutscher, J.,
and Haiech, J.
(1998)
Proc. Natl. Acad. Sci. U. S. A.
95,
1823-1828[Abstract/Free Full Text]
|
| 6.
|
Reizer, J.,
Hoischen, C.,
Titgemeyer, F.,
Rivolta, C.,
Rabus, R.,
Stülke, J.,
Karamata, D.,
Saier, M. H., Jr.,
and Hillen, W.
(1998)
Mol. Microbiol.
27,
1157-1169[CrossRef][Medline]
[Order article via Infotrieve]
|
| 7.
|
Brochu, D.,
and Vadeboncoeur, C.
(1999)
J. Bacteriol.
181,
709-717[Abstract/Free Full Text]
|
| 8.
|
Kravanja, M.,
Engelmann, R.,
Dossonnet, V.,
Blüggel, M.,
Meyer, H. E.,
Frank, R.,
Galinier, A.,
Deutscher, J.,
Schnell, N.,
and Hengstenberg, W.
(1999)
Mol. Microbiol.
31,
59-66[CrossRef][Medline]
[Order article via Infotrieve]
|
| 9.
|
Saier, M. J.
(1996)
FEMS Microbiol. Lett.
138,
97-103[CrossRef][Medline]
[Order article via Infotrieve]
|
| 10.
|
Galinier, A.,
Haiech, J.,
Kilhoffer, M. C.,
Jaquinod, M.,
Stülke, J.,
Deutscher, J.,
and Martin-Verstraete, I.
(1997)
Proc. Natl. Acad. Sci. U. S. A.
94,
8439-8444[Abstract/Free Full Text]
|
| 11.
|
Galinier, A.,
Deutscher, J.,
and Martin-Verstraete, I.
(1999)
J. Mol. Biol.
286,
307-314[CrossRef][Medline]
[Order article via Infotrieve]
|
| 12.
|
Deutscher, J.,
Küster, E.,
Bergstedt, U.,
Charrier, V.,
and Hillen, W.
(1995)
Mol. Microbiol.
15,
1049-1053[Medline]
[Order article via Infotrieve]
|
| 13.
|
Jones, B. E.,
Dossonnet, V.,
Küster, E.,
Hillen, W.,
Deutscher, J.,
and Klevit, R. E.
(1997)
J. Biol. Chem.
272,
26530-26535[Abstract/Free Full Text]
|
| 14.
|
Fujita, Y.,
Miwa, Y.,
Galinier, A.,
and Deutscher, J.
(1995)
Mol. Microbiol.
17,
953-960[CrossRef][Medline]
[Order article via Infotrieve]
|
| 15.
|
Gösseringer, R.,
Küster, E.,
Galinier, A.,
Deutscher, J.,
and Hillen, W.
(1997)
J. Mol. Biol.
266,
665-676[CrossRef][Medline]
[Order article via Infotrieve]
|
| 16.
|
Martin-Verstraete, I.,
Deutscher, J.,
and Galinier, A.
(1999)
J. Bacteriol.
181,
2966-2969[Abstract/Free Full Text]
|
| 17.
|
Taylor, S. S.,
Buechler, J. A.,
and Yonemoto, W.
(1990)
Annu. Rev. Biochem.
59,
971-1005[CrossRef][Medline]
[Order article via Infotrieve]
|
| 18.
|
Hunter, T.
(1995)
Cell
80,
225-236[CrossRef][Medline]
[Order article via Infotrieve]
|
| 19.
|
Walker, J. E.,
Saraste, M.,
Runswick, M. J.,
and Gay, N. J.
(1982)
EMBO J.
1,
945-951[Medline]
[Order article via Infotrieve]
|
| 20.
|
Saraste, M.,
Sibbald, P. R.,
and Wittinghofer, A.
(1990)
Trends Biochem. Sci.
15,
430-434[CrossRef][Medline]
[Order article via Infotrieve]
|
| 21.
|
Eccleston, J. F.,
Moore, K. J. M.,
Brownbridge, G. G.,
Webb, M. R.,
and Lowe, P. N.
(1991)
Biochem. Soc. Trans.
19,
432-436[Medline]
[Order article via Infotrieve]
|
| 22.
|
Jault, J.-M.,
Divita, G.,
Allison, W. S.,
and Di Pietro, A.
(1993)
J. Biol. Chem.
268,
20762-20767[Abstract/Free Full Text]
|
| 23.
|
Kanazawa, T.,
Suzuki, H.,
Daiho, T.,
and Yamasaki, K.
(1995)
Biosci. Rep.
15,
317-326[CrossRef][Medline]
[Order article via Infotrieve]
|
| 24.
|
Bauer, C. B.,
Kuhlman, P. A.,
Bagshaw, C. R.,
and Rayment, I.
(1997)
J. Mol. Biol.
274,
394-407[CrossRef][Medline]
[Order article via Infotrieve]
|
| 25.
|
Conseil, G.,
Baubichon-Cortay, H.,
Dayan, G.,
Jault, J.-M.,
Barron, D.,
and Di Pietro, A.
(1998)
Proc. Natl. Acad. Sci. U. S. A.
95,
9831-9836[Abstract/Free Full Text]
|
| 26.
|
Hiratsuka, T.
(1983)
Biochim. Biophys. Acta
742,
496-508[CrossRef][Medline]
[Order article via Infotrieve]
|
| 27.
|
Woodward, S. K.,
Eccleston, J. F.,
and Geeves, M. A.
(1991)
Biochemistry
30,
422-430[CrossRef][Medline]
[Order article via Infotrieve]
|
| 28.
|
Stafford, W. F.
(1992)
Anal. Biochem.
203,
295-301[CrossRef][Medline]
[Order article via Infotrieve]
|
| 29.
|
Philo, J. S.
(1994)
in
Modern Analytical Ultracentrifugation: Acquisition and Interpretation of Data for Biological and Synthetic Polymer Systems
(Schuster, T. M.
, and Laue, T. M., eds)
, pp. 156-170, Birkhausen, Boston
|
| 30.
|
Deutscher, J.,
Kessler, U.,
and Hengstenberg, W.
(1985)
J. Bacteriol.
163,
1203-1209[Abstract/Free Full Text]
|
| 31.
|
Divita, G.,
Goody, R. S.,
Gautheron, D. C.,
and Di Pietro, A.
(1993)
J. Biol. Chem.
268,
13178-13186[Abstract/Free Full Text]
|
| 32.
|
Divita, G.,
Di Pietro, A.,
Deleage, G.,
Roux, B.,
and Gautheron, D. C.
(1991)
Biochemistry
30,
3256-3262[CrossRef][Medline]
[Order article via Infotrieve]
|
| 33.
|
Calhoun, D. B.,
Vanderkooi, J. M.,
and Englander, S. W.
(1983)
Biochemistry
22,
1533-1539[CrossRef][Medline]
[Order article via Infotrieve]
|
| 34.
|
Eftink, M. R.,
and Ghiron, C. A.
(1976)
Biochemistry
15,
672-680[CrossRef][Medline]
[Order article via Infotrieve]
|
| 35.
|
Eftink, M. R.,
and Ghiron, C. A.
(1981)
Anal. Biochem.
114,
199-227[CrossRef][Medline]
[Order article via Infotrieve]
|
| 36.
|
Lehrer, S. S.
(1971)
Biochemistry
10,
3254-3263[CrossRef][Medline]
[Order article via Infotrieve]
|
| 37.
|
Koshland, D. E. J.,
Nemethy, G.,
and Filmer, D.
(1966)
Biochemistry
5,
365-385[CrossRef][Medline]
[Order article via Infotrieve]
|
| 38.
|
Monod, J.,
Wyman, J.,
and Changeux, J.-P.
(1965)
J. Mol. Biol.
12,
88-118[Medline]
[Order article via Infotrieve]
|
| 39.
|
Lakowicz, J. R.
(1983)
Principles of Fluorescence Spectroscopy
, 3rd Ed.
, Plenum Press, New York
|
| 40.
|
Ricard, J.,
and Cornish-Bowden, A.
(1987)
Eur. J. Biochem.
166,
255-272[Medline]
[Order article via Infotrieve]
|
| 41.
|
Kantrowitz, E. R.,
and Lipscomb, W. N.
(1990)
Trends Biochem. Sci.
15,
53-59[CrossRef][Medline]
[Order article via Infotrieve]
|
| 42.
|
Deutscher, J.,
and Saier, M. H., Jr.
(1983)
Proc. Natl. Acad. Sci. U. S. A.
80,
6790-6794[Abstract/Free Full Text]
|
| 43.
|
Mimura, C. S.,
Poy, F.,
and Jacobson, G. R.
(1987)
J. Cell. Biochem.
33,
161-171[CrossRef][Medline]
[Order article via Infotrieve]
|
| 44.
|
Thevenot, T.,
Brochu, D.,
Vadeboncoeur, C.,
and Hamilton, I. R.
(1995)
J. Bacteriol.
177,
2751-2759[Abstract/Free Full Text]
|
| 45.
|
Mitchell, W. J.,
Reizer, J.,
Herring, C.,
Hoischen, C.,
and Saier, M. H. J.
(1993)
J. Bacteriol.
175,
2758-2761[Abstract/Free Full Text]
|
| 46.
|
Christensen, D. P.,
Benson, A. K.,
and Hutkins, R. W.
(1999)
Appl. Environ. Microbiol.
65,
2112-2115[Abstract/Free Full Text]
|
| 47.
|
Fujita, Y.,
and Freese, E.
(1979)
J. Biol. Chem.
254,
5340-5349[Abstract/Free Full Text]
|
| 48.
|
Entian, K. D.,
and Barnett, J. A.
(1992)
Trends Biochem. Sci.
17,
506-510[CrossRef][Medline]
[Order article via Infotrieve]
|
| 49.
|
Murcott, T. H.,
Gutfreund, H.,
and Muirhead, H.
(1992)
EMBO J.
11,
3811-3814[Medline]
[Order article via Infotrieve]
|
| 50.
|
Mason, P. W.,
Carbone, D. P.,
Cushman, R. A.,
and Waggoner, A. S.
(1981)
J. Biol. Chem.
256,
1861-1866[Abstract/Free Full Text]
|
| 51.
|
Cameron, A. D.,
Roper, D. I.,
Moreton, K. M.,
Muirhead, H.,
Holbrook, J. J.,
and Wigley, D. B.
(1994)
J. Mol. Biol.
238,
615-625[CrossRef][Medline]
[Order article via Infotrieve]
|
| 52.
|
Ormo, M.,
Bystrom, C. E.,
and Remington, S. J.
(1998)
Biochemistry
37,
16565-16572[CrossRef][Medline]
[Order article via Infotrieve]
|
Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.
